Roles of hsa-miR-12462 and SLC9A1 in acute myeloid leukemia

[1]  Andrian A. Tarmaev,et al.  MiRNAs as promising biomarkers in cancer , 2019, HERALD of North-Western State Medical University named after I.I. Mechnikov.

[2]  Xiaowei Wang,et al.  miRDB: an online database for prediction of functional microRNA targets , 2019, Nucleic Acids Res..

[3]  Cai Han,et al.  Noncoding RNAs in cancer therapy resistance and targeted drug development , 2019, Journal of Hematology & Oncology.

[4]  X. Ke,et al.  Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia , 2019, Journal of Hematology & Oncology.

[5]  B. Rerkamnuaychoke,et al.  Cytogenetics and FLT3-ITD mutation predict clinical outcomes in non transplant patients with acute myeloid leukemia , 2019, Experimental Hematology & Oncology.

[6]  Benjamin A Hall,et al.  Exploring the role of stromal osmoregulation in cancer and disease using executable modelling , 2018, Nature Communications.

[7]  Jay W. Shin,et al.  An integrated expression atlas of miRNAs and their promoters in human and mouse , 2017, Nature Biotechnology.

[8]  Ji-Yeon Park,et al.  cAMP signaling increases histone deacetylase 8 expression via the Epac2–Rap1A–Akt pathway in H1299 lung cancer cells , 2017, Experimental &Molecular Medicine.

[9]  Guihua Chen,et al.  β-Arrestin1 enhances hepatocellular carcinogenesis through inflammation-mediated Akt signalling , 2015, Nature Communications.

[10]  P. Mishra,et al.  MicroRNAs as promising biomarkers in cancer diagnostics , 2014, Biomarker Research.

[11]  S. Grando,et al.  Connections of nicotine to cancer , 2014, Nature Reviews Cancer.

[12]  J. Rinn,et al.  Modular regulatory principles of large non-coding RNAs , 2012, Nature.

[13]  Claudiu T. Supuran,et al.  Interfering with pH regulation in tumours as a therapeutic strategy , 2011, Nature Reviews Drug Discovery.

[14]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..